Top Clinical Trials companies in Hong Kong by Receivables
Hong Kong
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 116.89 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
| 2 |
USD 70.17 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
| 3 |
USD 5.16 M
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
| 4 |
USD 427.11 K
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
| 5 |
USD 0.00
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest Receivables ?
The Clinical Trials company in Hong Kong with the highest Receivables is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD 116.89 M.
-
Which Clinical Trials company in Hong Kong has the lowest Receivables ?
The Clinical Trials company in Hong Kong with the lowest Receivables is Sirnaomics Ltd. (HKSE: 2257.HK) at USD 0.00.
-
What are the top 10 Clinical Trials companies in Hong Kong by Receivables ?
The top 10 Clinical Trials companies in Hong Kong by Receivables are HUTCHMED (China) Limited, Frontage Holdings Corporation, Prenetics Global Limited, Lee's Pharmaceutical Holdings Limited and Sirnaomics Ltd..
-
What are the bottom 10 Clinical Trials companies in Hong Kong by Receivables ?
The bottom 10 Clinical Trials companies in Hong Kong by Receivables are Sirnaomics Ltd., Lee's Pharmaceutical Holdings Limited, Prenetics Global Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
